|
End-of-day quote
Berne S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 135.88 CHF | -2.33% |
|
-1.13% | -6.19% |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09-30 | Major drugmakers turn to China for licensing deals | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.62% | -0.10% | -0.59% | -4.13% | +6.99% | +50.70% | +114.07% | +397.66% | +1,332.66% | 1,031B | |
| -2.30% | -3.90% | -2.70% | +1.85% | +24.99% | +39.50% | +66.07% | +60.16% | +118.96% | 638B | |
| -0.63% | -1.94% | +1.37% | +3.29% | +13.76% | +12.26% | +74.38% | +140.97% | +312.13% | 462B | |
| -1.03% | -2.88% | -2.67% | +11.91% | +36.62% | +71.35% | +39.69% | +91.47% | +130.43% | 359B | |
| -0.03% | -3.91% | -1.08% | +4.87% | +6.34% | +34.28% | +39.35% | +2.06% | +44.81% | 335B | |
| -1.58% | +0.39% | -4.22% | -6.73% | +7.72% | +17.92% | +25.77% | +53.66% | +54.53% | 273B | |
| -2.02% | -3.20% | +0.52% | -14.67% | -12.75% | +7.60% | +8.38% | +34.32% | +140.45% | 253B | |
| -3.38% | +0.29% | -5.26% | +12.47% | +24.43% | +44.32% | +51.54% | +91.52% | +144.15% | 228B | |
| -1.04% | -2.56% | +0.79% | +16.75% | +20.17% | +32.88% | +96.82% | +111.17% | +86.43% | 185B | |
| -1.26% | -0.89% | -14.50% | -20.53% | -23.14% | -27.46% | -61.17% | -19.54% | +81.55% | 170B | |
| -1.40% | -0.21% | -1.19% | +16.78% | +12.93% | +10.36% | -15.22% | -34.62% | -16.98% | 163B | |
| -3.07% | -1.86% | -6.94% | +2.02% | +11.77% | +29.39% | +45.72% | +179.36% | +481.06% | 133B | |
| -1.51% | +0.51% | -8.01% | +6.66% | +13.94% | +36.27% | +5.89% | +3.87% | +13.98% | 127B | |
| +5.27% | +2.08% | +1.52% | +18.95% | +9.57% | +16.35% | +106.70% | +350.81% | +439.02% | 99.55B | |
| -2.02% | -4.83% | -3.16% | -9.39% | -1.62% | +14.00% | +20.31% | +2.31% | -12.60% | 97.46B | |
| +0.63% | -0.01% | -4.83% | -2.64% | -11.63% | -6.94% | -27.97% | -12.01% | +8.07% | 98.83B | |
| -1.89% | +3.75% | +34.63% | +169.80% | +540.69% | +631.48% | +82.92% | -50.91% | - | 76.88B | |
| -3.09% | -8.36% | -8.04% | +17.84% | -4.80% | +30.69% | -10.71% | +21.42% | +82.78% | 75.72B | |
| -2.64% | +1.13% | -3.27% | -8.44% | +9.67% | +22.84% | -14.99% | -28.35% | +40.18% | 68.18B | |
| Average | -0.45% | +0.05% | -1.45% | +11.40% | +36.09% | +56.20% | +34.08% | +73.44% | +193.42% | 256.48B | |
| Weighted average by Cap. | -0.36% | -0.14% | -1.75% | +4.03% | +19.69% | +41.75% | +55.14% | +134.81% | +392.92% |
- Stock Market
- Stocks
- AZN Stock
- 000982352 Stock
- Sector AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
